19h
Hosted on MSNBlood Test for Early Pancreatic Cancer Shows PromiseHe noted that other assays studied in pancreatic cancer have only examined a handful of samples. "When they publish a second ...
By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...
A team of researchers from the Sant Pau Research Institute (IR Sant Pau) has published a study in the Journal of ...
There are many symptoms that are common to a wide variety of diseases, like fever, which can indicate an infection, autoimmune disease, or ... | Clinical And Molecular Dx ...
Background Early-life inflammation has long been recognised as a key pathophysiological process in the evolution of cystic ...
Trenchant partnered with Autolomous, integrating its digital solution into its CGT manufacturing platform, for faster production and lower costs.
Researchers have developed a groundbreaking AI model that identifies tumor-fighting immune cells, enhancing cancer ...
This study provides a valuable new resource to investigate the molecular basis of the particular features characterizing the pipefish embryo. The authors found both unique and shared gene expression ...
Scientists have progressed from merely provoking an anti-cancer immune response to designing it ...
Findings indicate that altering glucose metabolism in T cells boosts their therapeutic potential against melanoma, paving the way for improved immunotherapies.
Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, State Key Laboratory for Digestive Health, National Clinical Research Center for Digestive Disease, Beijing ...
A panel discussion during the JPMorgan conference earlier this month examined where oncology drug development is headed, driven in part by advances in diagnostic testing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results